A most cancers affected person would possibly stay in a city with 4 oncology teams, however just one accepts his insurance coverage — the one owned by his insurer. A younger couple might see big payments after their little one is born, as a result of their insurer agreed to the well being system’s charges in change for a contract with obstetricians throughout the nation. A lady might need to pay a giant sum she will be able to’t afford for primary lab assessments at a hospital — inflated charges her insurer accepted so its clients have entry to the system’s youngsters’s hospital elsewhere within the state.
And even well-insured sufferers obtain unaffordable payments on this period of high-deductible well being plans, slender insurance coverage networks, and 20% price sharing.
Well being programs, physician teams, and insurers are merging and coalescing into ever-bigger giants. Whereas these mergers are good for enterprise, research present the escalating consolidation in well being care is driving up costs, harming affected person outcomes, and lowering alternative for individuals who want care. A current research discovered that six years after hospitals acquired different hospitals, that they had raised costs by 12.9%, with hospitals that engaged in a number of acquisitions elevating their costs by 16.3%.
These new offers are “mutually enforced monopolization,” mentioned Barak Richman, the Alexander Hamilton professor of enterprise regulation at George Washington College. “It’s not competitors. It’s extra like collusion. They don’t care about worth.”
These market elements contributed to a panorama the place a dose of the antiviral Paxlovid given in a hospital prices $4,500; magnetic resonance imaging prices $15,000; and joint replacements price $100,000.
President Donald Trump has talked in regards to the burden of well being care prices since his first marketing campaign, however he has signaled that his administration’s regulators are much less inclined than his predecessor’s to intervene in well being mergers.
This summer time, he revoked President Joe Biden’s 2021 directive that every one federal companies make certain markets stay aggressive, reversing course from Biden’s extra expansive interpretation of antitrust regulation. And in a scathing assertion upon taking up the Federal Commerce Fee, Trump-appointed chair Andrew Ferguson blasted his predecessor, Lina Khan, implying that she had overstepped the company’s authorized authority, in addition to criticizing what he known as her “clumsy” and “breathless” rhetoric and her deal with the incursion of personal fairness into well being care.
What this may imply in observe is unclear.
In an interview with KFF Well being Information, Daniel Guarnera, the director of the FTC’s Bureau of Competitors, mentioned that the management on the FTC and the Justice Division has endorsed pointers issued by the Biden administration, which he characterised as a “framing system” for corporations considering a merger.
The expanded merger pointers, issued in 2023, centered for the primary time on all kinds of latest kinds of anti-competitive practices that had turn into widespread in well being care, akin to hospitals and personal fairness corporations shopping for docs’ practices and insurers proudly owning what are often called specialty pharmacies to dispense sophisticated and sometimes costly medication.
Guarnera famous that regulators’ strongest enforcement software is convincing a decide that mergers violate the Clayton Antitrust Act, a statute that’s the basis of antitrust regulation. However administrations can interpret this statute in another way, and it’s unclear what circumstances the Trump administration’s FTC will select to convey.
“The Biden administration tried to be extra revolutionary,” mentioned Erin Fuse Brown, a professor of well being providers, coverage, and observe at Brown College’s Faculty of Public Well being. “The Trump administration has signaled a extra conventional strategy — that it’s unwilling to push the envelope.”
Within the battle for earnings between insurers and suppliers, both sides insists it must develop greater to carry sway within the negotiations that decide well being care costs. However proof reveals the costs that make sense in industry-level dealmaking have little to do with the precise worth of the providers concerned. As a substitute, they’re merely a knowledge level in large-scale calculations that, at finest, replicate the facility steadiness between opposing events.
Underneath Trump, the FTC has already sued to dam two mergers of medical-device makers and has continued the Biden administration’s challenges of particular person drug patents.
“Serving to enhance the well being care system although guaranteeing that there’s extra and higher competitors are very, very excessive priorities for us on the FTC,” Guarnera mentioned, noting that well being care has “monumental results on each People’ pocketbooks in addition to well-being.”
However it’s far harder to tackle the extra huge entities, and although the variety of new mergers dipped early this yr as corporations navigated the unsure results of tariffs and rates of interest, consolidation continues.
A current Becker’s Hospital Evaluation article recognized “28 massive well being programs rising greater,” noting, “This isn’t an exhaustive checklist.”
For instance, in Could, Northwell Well being of New York merged with Connecticut’s Nuvance to turn into a 28-hospital behemoth with over 1,000 outpatient clinics. That was a extra conventional merger, the place hospitals in the identical area joined to increase their attain and improve their market energy.
In the meantime, corporations are creating powerhouses not beforehand seen in well being care, by racking up smaller purchases that aren’t costly sufficient to set off federal evaluation. They embody what are often called vertical mergers, which mix corporations that present totally different capabilities in the identical {industry} — mostly, hospital programs or insurers shopping for docs’ practices or specialty pharmacies.
As an illustration, UnitedHealth Group, the world’s largest well being care firm, now owns medical insurance plans; doctor practices and different suppliers; knowledge and analytics providers; fee processors; a pharmacy advantages supervisor; and pharmacies themselves. Jonathan Kanter, the competitors czar in Biden’s Justice Division, has likened the UnitedHealth amalgamation to Amazon.
Likewise, hospital programs and personal corporations — usually personal fairness corporations — are more and more increasing their attain to totally different areas, gobbling up hospitals, medical practices, and surgical procedure facilities. This sort of consolidation, often called a cross-market merger, permits corporations to build up big collections of docs — and important market energy — throughout the nation particularly specialties, akin to gastroenterology, ophthalmology, pediatrics, or obstetrics.
Analysis reveals a change in possession means a change in costs. Whereas pediatrics and obstetrics have historically been poorly paid specialties, for example, they signify a land of alternative to buyers as a result of dad and mom are prepared to pay extra relating to care for his or her youngsters.
It was once comparatively easy for regulators to discern when a hospital that merged with its close by competitor gained monopoly energy, rendering it anti-competitive and driving up costs. Well being researchers say these new, extra sophisticated kinds of offers, making a extra complicated interaction between insurers and medical suppliers, have made that tipping level a lot tougher to outline.
In well being care, much more conventional, vertical consolidation will be problematic, Richman mentioned. “Financial idea says it could possibly be innocuous, like a go well with producer opening a retailer, though research present in well being care it’s harmful — increased costs, poorer high quality, much less alternative,” he mentioned.
For instance, sufferers who’ve Cigna well being plans and wish an array of dearer, usually injectable prescriptions should use Accredo, the specialty pharmacy the insurer purchased in 2018, though a distinct pharmacy could have a greater worth.
Economists have developed laptop modeling to foretell when sufferers will expertise increased costs and fewer alternative due to these new kinds of consolidation. However judges who might nix the transactions are to date “not satisfied,” mentioned Daniel Arnold, a well being economist at Brown’s Faculty of Public Well being.
Consultants akin to Fuse Brown say new legal guidelines and enforcement instruments are wanted.
“The previous legal guidelines,” she mentioned, “are simply not calibrated to the complexity and novel kinds of mergers.”
(KFF Well being Information is a nationwide newsroom that produces in-depth journalism about well being points and is among the core working applications of KFF — the unbiased supply for well being coverage analysis, polling and journalism.)
©2025 KFF Well being Information. Distributed by Tribune Content material Company, LLC.
